BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deshayes S, Aouba A, Khoy K, Mariotte D, Lobbedez T, Martin Silva N. Hypocomplementemia is associated with worse renal survival in ANCA-positive granulomatosis with polyangiitis and microscopic polyangiitis. PLoS One 2018;13:e0195680. [PMID: 29621352 DOI: 10.1371/journal.pone.0195680] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Monti S, Brandolino F, Milanesi A, Xoxi B, Delvino P, Montecucco C. Novel Therapies for ANCA-associated Vasculitis. Curr Rheumatol Rep 2021;23:38. [PMID: 33909172 DOI: 10.1007/s11926-021-01010-0] [Reference Citation Analysis]
2 Lin W, Shen C, Zhong Y, Ooi JD, Eggenhuizen P, Zhou YO, Luo H, Huang J, Chen JB, Wu T, Meng T, Xiao Z, Ao X, Peng W, Tang R, Yin H, Xiao X, Zhou Q, Xiao P. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival. Front Immunol 2021;12:625672. [PMID: 33841408 DOI: 10.3389/fimmu.2021.625672] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Huang L, Shen C, Zhong Y, Ooi JD, Zhou YO, Chen JB, Wu T, Meng T, Xiao Z, Lin W, Ao X, Xiao X, Zhou Q, Xiao P. Risk factors for treatment resistance and relapse of Chinese patients with MPO-ANCA-associated vasculitis. Clin Exp Med 2020;20:199-206. [PMID: 32078076 DOI: 10.1007/s10238-020-00614-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
4 Cavalli S, Lonati PA, Gerosa M, Caporali R, Cimaz R, Chighizola CB. Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases. Front Pharmacol 2022;13:841785. [PMID: 35242041 DOI: 10.3389/fphar.2022.841785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lionaki S, Marinaki S, Liapis G, Kalaitzakis E, Fragkioudaki S, Kalogeropoulos P, Michelakis I, Goules A, Tzioufas AG, Boletis JN. Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated With Advanced Histopathological Activity Index and High Probability of Treatment Resistance. Kidney Int Rep 2021;6:2425-35. [PMID: 34514203 DOI: 10.1016/j.ekir.2021.05.043] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Moiseev S, Lee JM, Zykova A, Bulanov N, Novikov P, Gitel E, Bulanova M, Safonova E, Shin JI, Kronbichler A, Jayne DRW. The alternative complement pathway in ANCA-associated vasculitis: further evidence and a meta-analysis. Clin Exp Immunol 2020;202:394-402. [PMID: 32691878 DOI: 10.1111/cei.13498] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Alahmari H, Daajani HA, Alsayed F, Alrashid A. ANCA-Associated Vasculitis Clinical Presentation and Clinical Predictors of Relapse in Saudi Arabia. Open Access Rheumatol 2021;13:213-20. [PMID: 34305413 DOI: 10.2147/OARRR.S314421] [Reference Citation Analysis]
8 Quintana LF, Kronbichler A, Blasco M, Zhao MH, Jayne D. ANCA associated vasculitis: The journey to complement-targeted therapies. Mol Immunol 2019;112:394-8. [PMID: 31291610 DOI: 10.1016/j.molimm.2019.06.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
9 Wester Trejo MAC, Trouw LA, Bajema IM. The role of complement in antineutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Rheumatol 2019;31:3-8. [PMID: 30461541 DOI: 10.1097/BOR.0000000000000557] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Toraman A, Soysal Gündüz Ö. Predictors of renal and patient outcomes in anti-neutrophil cytoplasmic antibody-associated vasculitis: Our single-center, tertiary care experience. Arch Rheumatol 2021;36:445-57. [PMID: 34870177 DOI: 10.46497/ArchRheumatol.2021.8687] [Reference Citation Analysis]
11 Kronbichler A, Shin JI, Lee KH, Nakagomi D, Quintana LF, Busch M, Craven A, Luqmani RA, Merkel PA, Mayer G, Jayne DRW, Watts RA. Clinical associations of renal involvement in ANCA-associated vasculitis. Autoimmun Rev 2020;19:102495. [PMID: 32068190 DOI: 10.1016/j.autrev.2020.102495] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
12 Chalkia A, Thomas K, Giannou P, Panagiotopoulos A, Hadziyannis E, Kapota A, Gakiopoulou H, Vassilopoulos D, Petras D. Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort study. Ren Fail 2020;42:845-52. [PMID: 32787590 DOI: 10.1080/0886022X.2020.1803086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Hakroush S, Tampe D, Korsten P, Ströbel P, Tampe B. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis. Int J Mol Sci 2021;22:6588. [PMID: 34205415 DOI: 10.3390/ijms22126588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Warren K, Vu K, Shergill K, Watson B, Faris M. Rare complication of a commonly used antihypertensive agent: A case of hydralazine‐induced ANCA‐associated vasculitis presenting as rapidly progressive glomerulonephritis. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5411] [Reference Citation Analysis]
15 García L, Pena CE, Maldonado RÁ, Costi C, Mamberti M, Martins E, García MA. Increased renal damage in hypocomplementemic patients with ANCA-associated vasculitis: retrospective cohort study. Clin Rheumatol 2019;38:2819-24. [PMID: 31222573 DOI: 10.1007/s10067-019-04636-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
16 Sciascia S, Ponticelli C, Roccatello D. Pathogenesis-based new perspectives of management of ANCA-associated vasculitis. Autoimmun Rev 2021;:103030. [PMID: 34971805 DOI: 10.1016/j.autrev.2021.103030] [Reference Citation Analysis]
17 Brilland B, Garnier A, Chevailler A, Jeannin P, Subra J, Augusto J. Complement alternative pathway in ANCA-associated vasculitis: Two decades from bench to bedside. Autoimmunity Reviews 2020;19:102424. [DOI: 10.1016/j.autrev.2019.102424] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
18 Salama AD. Genetics and pathogenesis of small-vessel vasculitis. Best Pract Res Clin Rheumatol 2018;32:21-30. [PMID: 30526895 DOI: 10.1016/j.berh.2018.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
19 Ozen S, Batu ED. Vasculitis Pathogenesis: Can We Talk About Precision Medicine? Front Immunol 2018;9:1892. [PMID: 30154798 DOI: 10.3389/fimmu.2018.01892] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]